Literature DB >> 136287

Sodium valproate in chorea.

J A Lenman, I T Ferguson, A M Fleming, M Herzberg, J E Robb, M J Turnbull.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 136287      PMCID: PMC1689428          DOI: 10.1136/bmj.2.6044.1107-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  4 in total

1.  Letter: G.A.B.A. in Huntington's chorea.

Authors:  R Fisher; J W Norris; L Gilka
Journal:  Lancet       Date:  1974-03-23       Impact factor: 79.321

2.  Letter: G.A.B.A. and Huntington's chorea.

Authors:  A Barbeau
Journal:  Lancet       Date:  1973-12-29       Impact factor: 79.321

3.  Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid.

Authors:  I Shoulson; R Kartzinel; T N Chase
Journal:  Neurology       Date:  1976-01       Impact factor: 9.910

4.  Failure of increased brain gamma-aminobutyric acid levels to influence amphetamine-induced stereotyped behavior.

Authors:  B C Patel; P Crosset; H L Klawans
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-12
  4 in total
  6 in total

1.  Valproic acid in Sydenham's chorea.

Authors:  R S McLachlan
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-25

Review 2.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

Review 3.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

4.  Quantitative evaluation of functional capacity during isoniazid therapy in Huntington's disease.

Authors:  T Stober; K Schimrigk; G Holzer; B Ziegler
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  Dose-dependent improvement of myoclonic hyperkinesia due to Valproic acid in eight Huntington's Disease patients: a case series.

Authors:  Carsten Saft; Thorsten Lauter; Peter H Kraus; Horst Przuntek; Juergen E Andrich
Journal:  BMC Neurol       Date:  2006-02-28       Impact factor: 2.474

Review 6.  Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned?

Authors:  Lisa Scheuing; Chi-Tso Chiu; Hsiao-Mei Liao; Gabriel R Linares; De-Maw Chuang
Journal:  Int J Biol Sci       Date:  2014-09-10       Impact factor: 6.580

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.